Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Concentration in Glenohumeral Osteoarthritis
NCT03586687Phase 4Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jul 2018
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone in glenohumeral osteoarthritis (3 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Shoulder Pain and Disability Index at 6 months and Reactions to the Steroid at 6 months. Started Jul 2018; status: terminated.
02
Drugs
triamcinolone
03
Conditions
glenohumeral osteoarthritis
Beyond the preview
Go deeper on NCT03586687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586687.